Allan Pamba was appointed Director Public Engagement & Access Initiatives at GlaxoSmithKline in January 2011. His role focuses on the sustainable delivery of GSK medicines and vaccines to developing countries via innovative business models.
He is also responsible for directing GSK’s external engagement activities and setting up innovative initiatives to enhance access to medicines and vaccines across 50 countries, including the UN 48 Least Developed Countries.
Allan trained as a physician in Kenya and worked in clinical care in the country for government services, mission hospitals and research hospitals. He conducted clinical trials on the management of severe malaria in children at the WellcomeTrust Research Unit in Kilifi, Kenya and established one of the country’s first HIV Comprehensive Care Clinics.
He joined GSK in 2005 and was initially involved in strategic and tactical leadership of R&D programmes in Diseases of the Developing World, in particular HIV and malaria. He led medical governance for over 30 large HIV collaborative trials in Africa and Asia and led a phase III clinical development programme with two large trials in Africa developing a new anti-malarial medication.
He has an MSc in Public Health in Developing Countries from the London School of Hygiene & Tropical Medicine.
1Thanks Sachin -- hope you'll share your perspectives and experiences in the survey!
NextBillion.net | Finding A Responsible Way Forward For Digital Finance · 23 hours ago
Thanks for your comments, Dr. Rengarajan - you make some good points. And I don't have an answer...
NextBillion.net | Innovation Overkill · 2 days ago
Dear James Market leaders and followers are more concerned with the innovation be it for the...
Yes Hemant, I;d likewise love to know more about the program. Market oriented approaches abound...
NextBillion.net | It Takes an Ecosystem · 4 days ago
Great Initiative! very timely..
NextBillion.net | Finding A Responsible Way Forward For Digital Finance · 6 days ago